Shamsher Ahluwalia, MD
Psychiatry · Gastonia, NCNPI 1497943286
Payments from drug & device makers
Across 102 payments — averaging $17.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$392
- Neurocrine Biosciences, Inc.$271
- Johnson & Johnson$213
- Lundbeck LLC$175
- Sunovion Pharmaceuticals Inc.$171
- Teva Pharmaceuticals USA, Inc.$171
- plus $404 from 7 others
What the payments were for
- Food & beverage$1,797100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 20 | $392 |
| Neurocrine Biosciences, Inc. | 17 | $271 |
| Johnson & Johnson | 11 | $213 |
| Lundbeck LLC | 10 | $175 |
| Sunovion Pharmaceuticals Inc. | 11 | $171 |
| Teva Pharmaceuticals USA, Inc. | 11 | $171 |
| Alkermes, Inc. | 5 | $118 |
| Ironshore Pharmaceuticals Inc. | 6 | $102 |
| Arbor Pharmaceuticals, Inc. | 4 | $69 |
| Vanda Pharmaceuticals Inc. | 3 | $52 |
| Indivior Inc. | 2 | $30 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $18 |
| Adlon Therapeutics L.p. | 1 | $15 |
How this compares
$1,797 in reported general payments places this provider in the 75th percentile of 1,108 psychiatry providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aripiprazole | 22 | $1,584 |
| Olanzapine | 22 | $456 |
| Hydroxyzine Pamoate | 16 | $299 |
| Trazodone Hcl | 35 | $261 |
| Quetiapine Fumarate | 27 | $247 |
| Pantoprazole Sodium | 16 | $194 |
| Oxcarbazepine | 11 | $141 |
| Benztropine Mesylate | 15 | $132 |
| Risperidone | 11 | $92 |
| Buspirone Hcl | 12 | $87 |
| Atorvastatin Calcium | 11 | $51 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Gastonia
- Ramesh GihwalaGastonia$545K
- Craig ChepkeHuntersville$4.1M
- James BarkerHickory$4.1M
- Mark ReynoldsDurham$3.2M
- Oleg TcheremissineCharlotte$2M
- Richard WeislerRaleigh$1.2M
- Dan BlazerDurham$1M
- Samantha Meltzer-BrodyChapel Hill$909K
- Andrew KrystalDurham$754K
- Brian FarahWinston Salem$605K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.